Literature DB >> 23179159

Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women.

Monika Sarkar1, Peter Bacchetti, Phyllis Tien, Elizabeth Mileti, Audrey L French, Brian R Edlin, Marla Keller, Eric Seaberg, Marek J Nowicki, Mary Young, Marion G Peters.   

Abstract

BACKGROUND/AIMS: Among individuals without human immunodeficiency virus (HIV), African Americans have lower spontaneous clearance of hepatitis C virus (HCV) than Caucasians, and women have higher clearance than men. Few studies report racial/ethnic differences in acute HCV in HIV infected, or Hispanic women. We examined racial/ethnic differences in spontaneous HCV clearance in a population of HCV mono- and co-infected women.
METHODS: We conducted a cross sectional study of HCV seropositive women (897 HIV infected and 168 HIV uninfected) followed in the US multicenter, NIH-funded Women's Interagency HIV Study (WIHS), to determine the association of race/ethnicity with spontaneous HCV clearance, as defined by undetectable HCV RNA at study entry.
RESULTS: Among HIV and HCV seropositive women, 18.7 % were HCV RNA negative, 60.9 % were African American, 19.3 % Hispanic and 17.7 % Caucasian. HIV infected African American women were less likely to spontaneously clear HCV than Hispanic (OR 0.59, 95 % CI 0.38-0.93, p = 0.022) or Caucasian women (OR 0.57, 95 % CI 0.36-0.93, p = 0.023). Among HIV uninfected women, African Americans had less HCV clearance than Hispanics (OR 0.18, 95 % CI 0.07-0.48, p = 0.001) or Caucasians (OR 0.26, 95 % CI 0.09-0.79, p = 0.017). There were no significant differences in HCV clearance between Hispanics and Caucasians, among either HIV infected (OR 0.97, 95 % CI 0.57-1.66, p = 0.91) or uninfected (OR 1.45, 95 % CI 0.56-3.8, p = 0.45) women.
CONCLUSIONS: African Americans were less likely to spontaneously clear HCV than Hispanics or Caucasians, regardless of HIV status. No significant differences in spontaneous HCV clearance were observed between Caucasian and Hispanic women. Future studies incorporating IL28B genotype may further explain these observed racial/ethnic differences in spontaneous HCV clearance.

Entities:  

Mesh:

Year:  2012        PMID: 23179159      PMCID: PMC3663918          DOI: 10.1007/s10620-012-2486-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort.

Authors:  L N Clausen; N Weis; K Astvad; K Schønning; M Fenger; H Krarup; J Bukh; T Benfield
Journal:  J Viral Hepat       Date:  2010-11-12       Impact factor: 3.728

2.  A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME).

Authors:  Leslie H Tobler; Shrein H Bahrami; Zhanna Kaidarova; Lubov Pitina; Valarie K Winkelman; Sandra K Vanderpool; Anne M Guiltinan; Stewart Cooper; Michael P Busch; Edward L Murphy
Journal:  Transfusion       Date:  2010-03-25       Impact factor: 3.157

3.  45-year follow-up of hepatitis C virus infection in healthy young adults.

Authors:  L B Seeff; R N Miller; C S Rabkin; Z Buskell-Bales; K D Straley-Eason; B L Smoak; L D Johnson; S R Lee; E L Kaplan
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

4.  Perspective: test and treat this silent killer.

Authors:  Brian R Edlin
Journal:  Nature       Date:  2011-05-25       Impact factor: 49.962

5.  Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County.

Authors:  M Bonacini; M D Groshen; M C Yu; S Govindarajan; K L Lindsay
Journal:  Am J Gastroenterol       Date:  2001-08       Impact factor: 10.864

6.  Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group.

Authors:  Kenneth E Sherman; Susan D Rouster; Raymond T Chung; Natasa Rajicic
Journal:  Clin Infect Dis       Date:  2002-02-06       Impact factor: 9.079

7.  Treatment of acute hepatitis C in HIV infection.

Authors:  Martin Vogel; Jürgen K Rockstroh
Journal:  J Antimicrob Chemother       Date:  2010-01       Impact factor: 5.790

8.  Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.

Authors:  Andri Rauch; Zoltán Kutalik; Patrick Descombes; Tao Cai; Julia Di Iulio; Tobias Mueller; Murielle Bochud; Manuel Battegay; Enos Bernasconi; Jan Borovicka; Sara Colombo; Andreas Cerny; Jean-François Dufour; Hansjakob Furrer; Huldrych F Günthard; Markus Heim; Bernard Hirschel; Raffaele Malinverni; Darius Moradpour; Beat Müllhaupt; Andrea Witteck; Jacques S Beckmann; Thomas Berg; Sven Bergmann; Francesco Negro; Amalio Telenti; Pierre-Yves Bochud
Journal:  Gastroenterology       Date:  2010-01-11       Impact factor: 22.682

9.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

Authors:  Dongliang Ge; Jacques Fellay; Alexander J Thompson; Jason S Simon; Kevin V Shianna; Thomas J Urban; Erin L Heinzen; Ping Qiu; Arthur H Bertelsen; Andrew J Muir; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

View more
  8 in total

1.  Universal HCV Screening of Baby Boomers is Feasible, but It is Difficult.

Authors:  Paul J Thuluvath; Joshua Trowell; Talan Zhang; Joseph Alukal; George Lowe
Journal:  J Clin Exp Hepatol       Date:  2021-02-25

2.  Racial disparities in the proportion of current, unresolved hepatitis C virus infections in the United States, 2003-2010.

Authors:  Gui Liu; Scott D Holmberg; Saleem Kamili; Fujie Xu
Journal:  Dig Dis Sci       Date:  2014-02-27       Impact factor: 3.199

3.  Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.

Authors:  Erin M Kelly; Jennifer L Dodge; Monika Sarkar; Audrey L French; Phyllis C Tien; Marshall J Glesby; Elizabeth T Golub; Michael Augenbraun; Michael Plankey; Marion G Peters
Journal:  Clin Infect Dis       Date:  2016-05-25       Impact factor: 9.079

4.  Cohort Profile: The Women's Interagency HIV Study (WIHS).

Authors:  Adaora A Adimora; Catalina Ramirez; Lorie Benning; Ruth M Greenblatt; Mirjam-Colette Kempf; Phyllis C Tien; Seble G Kassaye; Kathryn Anastos; Mardge Cohen; Howard Minkoff; Gina Wingood; Igho Ofotokun; Margaret A Fischl; Stephen Gange
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

5.  Moderate Alcohol Use Is Not Associated With Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women: A Prospective Cohort Study.

Authors:  Erin M Kelly; Jennifer L Dodge; Peter Bacchetti; Monika Sarkar; Audrey L French; Phyllis C Tien; Marshall J Glesby; Elizabeth T Golub; Michael Augenbraun; Michael Plankey; Marion G Peters
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

6.  Association of cytokine gene polymorphisms with hepatitis C virus infection in a population from Rio de Janeiro, Brazil.

Authors:  Gustavo Milson Fabrício-Silva; Bruno Silva Poschetzky; Renata de Mello Perez; Ronaldo Carneiro Dos Santos; Luciana Tricai Cavalini; Luís Cristóvão Porto
Journal:  Hepat Med       Date:  2015-11-02

7.  The Associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C Virus Spontaneous Clearance Are Independent of IL28B in the Chinese Population.

Authors:  Jieting Huang; Ke Huang; Ru Xu; Min Wang; Qiao Liao; Huaping Xiong; Chengyao Li; Xi Tang; Zhengang Shan; Ming Zhang; Xia Rong; Kenrad Nelson; Yongshui Fu
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

8.  Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010.

Authors:  Eric W Hall; Eli S Rosenberg; Patrick S Sullivan
Journal:  BMC Infect Dis       Date:  2018-05-16       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.